StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:52 UTC

BCRX — BioCryst Pharmaceuticals, Inc.

UNDERVALUED (MOS +87.6%) · Quality 55/100

Price
8.68
Intrinsic value
69.99
Margin of safety
+87.6%
Implied growth (reverse DCF)
-11.1%
model assumes +16.0%
Value Score
43.4
Quality
55
Psychology
15
Discovery
34.5
price/volume attention only
Moat score
74.2
erosion: none

Value Score: top 28% of Russell 3000 · Quality: top 46%

Open the interactive Deep Dive for BCRX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/BCRX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is BCRX undervalued?

As of 2026-09-19, BCRX trades at 8.68 against a computed intrinsic value of 69.99 (+87.6% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is BioCryst Pharmaceuticals, Inc.'s Value Score?

BioCryst Pharmaceuticals, Inc.'s Value Score is 43.4 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.